The first product liability trial over claims that Takeda Pharmaceutical’s diabetes drug Actos caused bladder cancer was tossed out of court more than two years ago, but a California appeal court recently ruled to reinstate a $6.5 million jury award against the Japanese drug company. On July 16, 2015, the appeals court held...
Tag Archives: actos
As of September 2015, 97% of potential claimants have signed up to receive a portion of the $2.3 billion settlement that was announced in April 2015 between Takeda Pharmaceuticals and plaintiffs claiming that Takeda’s diabetes drug Actos caused their bladder cancer. In the process of attracting claimants, Takeda settled 7 of the 9 cases that had already gone...Read more
Just a few months after Takeda Pharmaceuticals settled claims for $2.37 million over its diabetes drug Actos allegedly causing bladder cancer, a new study suggests that the medication may also pose an increased risk of pancreatic and prostate cancers. Published in July 2015 in the Journal of American Medical Association, researchers found that after...Read more
A series of lawsuit settlement conferences are scheduled to take place over the next 12 months related to the diabetes drug Actos. More than 4,000 cases pending in federal courts nationwide all similarly allege that the drugmaker Takeda Pharmaceuticals failed to sufficiently warn of the risks Actos carried in causing bladder cancer. Since 2011, many...Read more